M&A Deal Summary |
|
|---|---|
| Date | 2025-11-05 |
| Target | National Test Systems |
| Sector | Medical Products |
| Buyer(s) | Premier Biotech |
| Deal Type | Add-on Acquisition |
SEARCH BY
| Category | Company |
|---|---|
| Founded | 2009 |
| Sector | Life Science |
Premier Biotech is a provider of point-of-care and rapid drugs of abuse diagnostic testing devices supported by an accredited laboratory. The Company’s products and corresponding laboratory services are used in the workplace (hiring and safety applications), government (child and family services, criminal justice, corrections and DOT applications) and clinical (medication monitoring) segments. Premier Biotech was founded in 2009 and is based in Minneapolis, Minnesota.
| DEAL STATS | # |
|---|---|
| Overall | 2 of 2 |
| Sector: Medical Products M&A | 1 of 1 |
| Type: Add-on Acquisition M&A Deals | 2 of 2 |
| State: Florida M&A | 1 of 1 |
| Country: United States M&A | 2 of 2 |
| Year: 2025 M&A | 1 of 1 |
| DATE | TARGET | DEAL TYPE | VALUE |
|---|---|---|---|
| 2024-06-06 |
DesertTox
Scottsdale, Arizona, United States DesertTox provides certified laboratory testing services for the Substance Abuse and Mental Health Services Administration (“SAMHSA”). The company serves customers throughout the United States across a broad range of end markets, including HHS/DOT, employment, occupational health, and government markets. DesertTox is based in Scottsdale, Arizona. |
Buy | - |
